HUP0302309A2 - Eljárás elhízás kezelésére és/vagy megelőzésére alkalmas vegyületek megtalálására és ezeket tartalmazó gyógyszerkészítmények előállítására - Google Patents

Eljárás elhízás kezelésére és/vagy megelőzésére alkalmas vegyületek megtalálására és ezeket tartalmazó gyógyszerkészítmények előállítására

Info

Publication number
HUP0302309A2
HUP0302309A2 HU0302309A HUP0302309A HUP0302309A2 HU P0302309 A2 HUP0302309 A2 HU P0302309A2 HU 0302309 A HU0302309 A HU 0302309A HU P0302309 A HUP0302309 A HU P0302309A HU P0302309 A2 HUP0302309 A2 HU P0302309A2
Authority
HU
Hungary
Prior art keywords
obesity
treatment
compounds
prophylaxis
preparation
Prior art date
Application number
HU0302309A
Other languages
English (en)
Inventor
Jochen Antel
Samuel David
Johannes Hebebrand
Ulf Preuschoff
Holger Sann
Michael Weske
Original Assignee
Solvay Pharmaceuticals Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharmaceuticals Gmbh filed Critical Solvay Pharmaceuticals Gmbh
Publication of HUP0302309A2 publication Critical patent/HUP0302309A2/hu
Publication of HUP0302309A3 publication Critical patent/HUP0302309A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • C12Q1/32—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving dehydrogenase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/527—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving lyase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

A találmány elhízás kezelésére és/vagy megelőzésére alkalmasvegyületek megtalálására irányuló eljárásra vonatkozik, amely szerintmeghatározzák, hogy a vizsgálandó vegyületek emlősökben és/vagyemberben a de-novo-lipogenézis gátlására képesek-e. A találmány tárgyatovábbá emlősállatokban a de-novo-lipogenézis gátlására képesvegyületek felhasználása elhízás kezelésére és/vagy megelőzésérealkalmas gyógyászati készítmény előállítására. Ó
HU0302309A 2000-07-20 2001-07-12 Method for locating compounds which are suitable for the treatment and/or prophylaxis of obesity and for preparation of pharmaceutical compositions containing them HUP0302309A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10035227A DE10035227A1 (de) 2000-07-20 2000-07-20 Verfahren zum Auffinden von Verbindungen, welche zur Behandlung und/oder Prophylaxe von Fettleibigkeit geeignet sind
PCT/EP2001/008051 WO2002007821A1 (de) 2000-07-20 2001-07-12 Verfahren zum auffinden von verbindungen, welche zur behandlung und/oder prophylaxe von obesitas geeignet sind

Publications (2)

Publication Number Publication Date
HUP0302309A2 true HUP0302309A2 (hu) 2003-11-28
HUP0302309A3 HUP0302309A3 (en) 2005-06-28

Family

ID=7649538

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0302309A HUP0302309A3 (en) 2000-07-20 2001-07-12 Method for locating compounds which are suitable for the treatment and/or prophylaxis of obesity and for preparation of pharmaceutical compositions containing them

Country Status (27)

Country Link
EP (1) EP1307262B1 (hu)
JP (1) JP2004504053A (hu)
KR (1) KR100818827B1 (hu)
CN (1) CN1443085B (hu)
AR (1) AR028730A1 (hu)
AT (1) ATE278441T1 (hu)
AU (2) AU2001277534B9 (hu)
BR (1) BR0112547A (hu)
CA (1) CA2416647A1 (hu)
CZ (1) CZ2003156A3 (hu)
DE (2) DE10035227A1 (hu)
DZ (1) DZ3393A1 (hu)
ES (1) ES2230346T3 (hu)
HK (1) HK1057499A1 (hu)
HU (1) HUP0302309A3 (hu)
IL (2) IL153971A0 (hu)
MX (1) MXPA02012907A (hu)
NO (1) NO20030233L (hu)
NZ (1) NZ523960A (hu)
PL (1) PL201165B1 (hu)
PT (1) PT1307262E (hu)
RU (1) RU2268721C2 (hu)
SK (1) SK287607B6 (hu)
TR (1) TR200402670T4 (hu)
TW (1) TWI274157B (hu)
UA (1) UA74588C2 (hu)
WO (1) WO2002007821A1 (hu)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1997370B (zh) 2004-05-19 2011-06-01 索尔瓦药物有限公司 N-氨磺酰-n＇-芳基哌嗪类化合物在制备用于预防或治疗肥胖和相关疾病的药物中的用途
MY147767A (en) 2004-06-16 2013-01-31 Janssen Pharmaceutica Nv Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
KR20080012360A (ko) 2005-05-20 2008-02-11 얀센 파마슈티카 엔.브이. 설파미드 유도체의 제조 방법
AR057570A1 (es) 2005-11-14 2007-12-05 Solvay Pharm Gmbh Derivados de n-sulfamoil-n'-benzopiranopiperidinas espirocondensadas, composiciones farmaceuticas que los comprenden, un procedimiento para su preparacion y su uso en la preparacion de medicamentos para el tratamiento de enfermedades mediadas por las isoenzimas anhidrasas carbonicas subtipos ii y/o
US8492431B2 (en) * 2005-12-19 2013-07-23 Janssen Pharmaceutica, N.V. Use of benzo-fused heterocycle sulfamide derivatives for the treatment of obesity
US8937096B2 (en) 2005-12-19 2015-01-20 Janssen Pharmaceutica Nv Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder
US8497298B2 (en) 2005-12-19 2013-07-30 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
US8691867B2 (en) 2005-12-19 2014-04-08 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction
US8716231B2 (en) 2005-12-19 2014-05-06 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain
TW200812573A (en) 2006-05-19 2008-03-16 Janssen Pharmaceutica Nv Co-therapy for the treatment of epilepsy and related disorders
NO2106260T3 (hu) 2007-01-25 2018-05-05
US8809385B2 (en) 2008-06-23 2014-08-19 Janssen Pharmaceutica Nv Crystalline form of (2S)-(-)-N-(6-chloro-2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl)-sulfamide
US8815939B2 (en) 2008-07-22 2014-08-26 Janssen Pharmaceutica Nv Substituted sulfamide derivatives
KR20150023405A (ko) * 2012-05-24 2015-03-05 베바 파마슈티칼스 엘티디 간 기능 개선 방법
CN106770611B (zh) * 2016-12-22 2019-01-29 广西师范大学 一种用于细胞原位检测小分子化合物进入线粒体的方法
RU2771430C1 (ru) * 2021-09-21 2022-05-04 Федеральное государственное бюджетное научное учреждение "Научный центр неврологии" (ФГБНУ НЦН) Способ количественного определения антиконвульсантов в плазме крови больных эпилепсией

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4552897A (en) * 1983-02-01 1985-11-12 American Cyanamid Company Salts of 1-(aminodihalophenyl)-2-aminoethanols and antilipogenic compositions prepared therefrom
US6288095B1 (en) * 1987-09-04 2001-09-11 Beecham Group P.L.C. Compounds
US5126324A (en) * 1990-06-07 1992-06-30 Genentech, Inc. Method of enhancing growth in patients using combination therapy
JPH08502969A (ja) * 1992-10-29 1996-04-02 ジェネンテク，インコーポレイテッド 肥満の予防または治療方法
AU693478B2 (en) * 1994-11-10 1998-07-02 Metabolic Pharmaceuticals Limited Treatment of obesity
CA2258893C (en) * 1996-06-28 2005-06-14 Ortho-Mcneil Pharmaceutical, Inc. Anticonvulsant sulfamate derivatives useful in treating obesity
US20030100594A1 (en) * 2001-08-10 2003-05-29 Pharmacia Corporation Carbonic anhydrase inhibitor

Also Published As

Publication number Publication date
HK1057499A1 (en) 2004-04-08
ATE278441T1 (de) 2004-10-15
RU2268721C2 (ru) 2006-01-27
PT1307262E (pt) 2004-12-31
EP1307262B1 (de) 2004-10-06
CN1443085A (zh) 2003-09-17
IL153971A (en) 2009-07-20
AU2001277534B9 (en) 2006-02-23
UA74588C2 (en) 2006-01-16
EP1307262A1 (de) 2003-05-07
AU7753401A (en) 2002-02-05
TWI274157B (en) 2007-02-21
CA2416647A1 (en) 2003-01-20
BR0112547A (pt) 2003-07-01
SK287607B6 (sk) 2011-03-04
IL153971A0 (en) 2003-07-31
KR100818827B1 (ko) 2008-04-01
MXPA02012907A (es) 2003-09-22
AR028730A1 (es) 2003-05-21
HUP0302309A3 (en) 2005-06-28
PL201165B1 (pl) 2009-03-31
NO20030233D0 (no) 2003-01-17
NZ523960A (en) 2004-12-24
DE50104023D1 (de) 2004-11-11
DZ3393A1 (fr) 2002-01-31
SK612003A3 (en) 2003-06-03
AU2001277534B2 (en) 2005-09-29
WO2002007821A1 (de) 2002-01-31
NO20030233L (no) 2003-03-19
CN1443085B (zh) 2010-04-28
DE10035227A1 (de) 2002-01-31
PL363518A1 (en) 2004-11-29
KR20030022284A (ko) 2003-03-15
JP2004504053A (ja) 2004-02-12
TR200402670T4 (tr) 2004-11-22
ES2230346T3 (es) 2005-05-01
CZ2003156A3 (cs) 2003-06-18

Similar Documents

Publication Publication Date Title
HUP0302309A2 (hu) Eljárás elhízás kezelésére és/vagy megelőzésére alkalmas vegyületek megtalálására és ezeket tartalmazó gyógyszerkészítmények előállítására
YU60903A (sh) Kompozicija i antivirusna aktivnost derivata supstituisanog azaindoloksoacetat piperazina
HUP0102550A2 (hu) IgE választ befolyásoló tulajdonságú vegyületek
NO20052739L (no) CCR5-antagonister som medikamenter
HUP0202570A1 (hu) Izoflavonokat és analogonjait tartalmazó készítmények és terápiás alkalmazásuk
DE60323765D1 (de) Inhibitoren der 17 beta-hydroxysteroiddehydrogenase des typs 3 zur behandlung androgenabhängiger krankheiten
EP1562897A4 (en) PHENYL ACARBOXAMIDE AS A BETA SEKRETASE INHIBITOR FOR THE TREATMENT OF ALZHEIMER
SE0102315D0 (sv) Compounds
HUP0102160A2 (hu) Alfa-keto-enamin-származékok alkalmazása alkotórészként
HUP0303363A2 (hu) Kináz-inhibitor hatású heterociklusos vegyületek alkalmazása gyógyszerkészítmények előállítására
ATE411985T1 (de) Substituierte piperazine als modulatoren des melanocortinrezeptors
HK1062677A1 (en) 17Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
HUP0104318A2 (hu) cGMP PDE-5 inhibitort tartalmazó szabályzottan hatóanyagot felszabadító gyógyászati készítmények
HUP0000487A2 (hu) Neurokinin antagonistaként alkalmazható szubsztituált oximszármazékok
RS20050108A (en) Compositions and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
MY134480A (en) 4-pyrrolidino-phenyl-benzyl ether derivatives
HUP0301819A2 (hu) Illóolajok alkalmazása Helicobacter-szerű organizmusok által előidézett gyomor- és bélrendszeri fertőzések leküzdésére
SI1456380T1 (sl) Smad inhibitorji za zdravljenje cns bolezni
HUP0001632A2 (hu) Szelektív foszfodiészteráz PDE enzim inhibitort tartalmazó gyógyszerkészítmények
HUP0402577A2 (hu) Citoszol foszfolipáz A2 inhibitor hatású indolszármazékok, eljárás előállításukra
MXPA04003611A (es) Piperidina- y piperazinacetaminas como inhibidores de la 17 beta-hidroxiesteroide deshidrogenasa tipo 3 para el tratamiento de enfermedades androgeno-dependientes.
WO2002059084A3 (en) Inhibitors of adp-ribosyl transferases, cyclases, and hydrolases, and uses thereof
DK1124841T3 (da) Substituerede phenylalkenoylguanidiner, fremgangsmåde til fremstilling deraf, anvendelse deraf som lægemidler eller diagnosemidler og lægemidler, som indeholder dem
HUP0002346A1 (hu) Emlősök elmezavarainak kezelésére szolgáló gyógyszerkészítmény
NO20033318D0 (no) 2H-1-benzopyranderivater, fremgangsmåte ved fremstilling samt farmasöytiskesammensetninger derav

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees